Rivaroxaban

Description du produit

Rivaroxaban is an active substance from the group of anticoagulants that inhibits blood clotting. It is mainly used to prevent thromboses and strokes and for the treatment of pulmonary embolisms. Rivaroxaban is taken by mouth in the form of tablets.

Comprehensive documentation for drug registration of Rivaroxaban can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
366789-02-8 ASMF IH

Tradename(s)

Rivaroxaban (Anticoagulant)

Disponibilité pays

Disponible dans le monde entier

Marta Ackermann

Interlocuteur

Marta Ackermann

Sales Manager


email   phone